Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4

Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease

Smit, J., Schinkel, A. H., Elferink, R. P. J. O., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van ROON, M. A., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90380-9 · Cited by 1,443 · see citing works

The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver

Gerloff, T., Stieger, B., Hagenbuch, B., Madon, J., Landmann, L., Roth, J., Hofmann, A. F., & Meier, P. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.10046 · Cited by 938 · see citing works

Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor

Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916 · see citing works

Mutations in the MDR 3 gene cause progressive familial intrahepatic cholestasis

de Vree, J. M. L., Jacquemin, E., Sturm, E., Cresteil, D., Bosma, P. J., Aten, J., Deleuze, J., Desrochers, M., Burdelski, M. M., Bernard, O., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.282 · Cited by 732 · see citing works

Phosphatidylcholine translocase: A physiological role for the mdr2 gene

Ruetz, S. (1994) · Cell · doi:10.1016/0092-8674(94)90446-4 · Cited by 599 · see citing works

The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood

Jacquemin, E., Bernard, O., Hadchouel, M., Cresteil, D., de Vree, J. M. L., Paul, M., Elferink, R. P. J. O., Bosma, P. J., Sokal, E. M., Sturm, E., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.23984 · Cited by 522 · see citing works

Characterization of the Human Multidrug Resistance Protein Isoform Mrp3 Localized to the Basolateral Hepatocyte Membrane

König, J., Rost, D., Cui, Y., & KEPPLER, D. O. R. (1999) · Hepatology · doi:10.1002/hep.510290404 · Cited by 503 · see citing works

A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.

Taniguchi, K., WADA, M., Kohno, K., Nakamura, T., Kawabe, T., Kawakami, M., Kagotani, K., Okumura, K., Akiyama, S.-I., & Kuwano, M. (1996) · PubMed · Cited by 470 · see citing works

Peroxisome proliferator activated receptor-alpha expression in human liver.

Palmer, C. N., Hsu, M. H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · PubMed · Cited by 448 · see citing works

Peroxisome Proliferator Activated Receptor-α Expression in Human Liver

Palmer, C. N. A., Hsu, M.-H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.14 · Cited by 416 · see citing works

Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis.

Th, M., van Nieuwkerk, C. M., Dingemans, K. P., Smit, J. J., Schinkel, A. H., Notenboom, R. G. E., Weerman, M. A. V. D. B., VERKRUISEN, R. P., Groen, A. K., & Elferink, R. P. J. O. (1994) · PubMed Central · Cited by 352 · see citing works

MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis

Rosmorduc, O., Poupon, R. Y., & Hermelin, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.23947 · Cited by 337 · see citing works

Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking

Dixon, P. H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1209 · Cited by 312 · see citing works

ABCB4 gene mutation-associated cholelithiasis in adults

Rosmorduc, O., Hermelin, B., Boelle, P., Parc, R., Taboury, J., & Poupon, R. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00898-9 · Cited by 282 · see citing works

MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide Trapping

Smith, A. J., van Helvoort, A., Gerrit van, M. E. E. R., Szabó, K., Welker, E., Szakács, G., Váradi, A., Sarkadi, B., & Borst, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909002199 · Cited by 248 · see citing works

Tauroursodeoxycholic Acid Inserts the Apical Conjugate Export Pump, Mrp2, Into Canalicular Membranes and Stimulates Organic Anion Secretion by Protein Kinase C-Dependent Mechanisms in Cholestatic Rat Liver

Beuers, U. H., Bilzer, M., CHITTATTU, A., Kullak-Ublick, G. A., KEPPLER, D. O. R., Paumgartner, G., & Dombrowski, F. (2001) · Hepatology · doi:10.1053/jhep.2001.24034 · Cited by 246 · see citing works

Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse.

Elferink, R. P. J. O., Ottenhoff, R., van Wijland, M. J. A., Smit, J., Schinkel, A. H., & Groen, A. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117658 · Cited by 225 · see citing works

Differential Gene Regulation in Human Versus Rodent Hepatocytes by Peroxisome Proliferator-activated Receptor (PPAR) α

Lawrence, J. W., Li, Y., Chen, S., DeLuca, J. G., Berger, J. P., Umbenhauer, D. R., Moller, D. E., & Zhou, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103306200 · Cited by 190 · see citing works

Tauroursodesoxycholate-induced choleresis involves p38MAPK activation and translocation of the bile salt export pump in rats

Kurz, A. K., Graf, D., Schmitt, M., Dahl, S. V., & Häussinger, D. (2001) · Gastroenterology · doi:10.1053/gast.2001.26262 · Cited by 168 · see citing works

Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice

Kok, T., Bloks, V. W., Wolters, H., Havinga, R., Jansen, P. L. M., Staels, B., & Kuipers, F. (2003) · Biochemical Journal · doi:10.1042/bj20020981 · Cited by 161 · see citing works

Spontaneous cholecysto- and hepatolithiasis in Mdr2 −/− mice: A model for low phospholipid-associated cholelithiasis†

Lammert, F., Wang, D. Q. ‐., Hillebrandt, S., Geier, A., Fickert, P., Trauner, M. A., Matern, S., Paigen, B. J., & Carey, M. C. (2004) · Hepatology · doi:10.1002/hep.20022 · Cited by 157 · see citing works

Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy.

Crawford, A. R., Smith, A. J., Hatch, V., Elferink, R. P. J. O., Borst, P., & Crawford, J. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119799 · Cited by 155 · see citing works

Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis

Choudhuri, B. S., Bhakta, S., Barik, R., Basu, J., Kundu, M., & Chakrabarti, P. (2002) · Biochemical Journal · doi:10.1042/bj20020615 · Cited by 151 · see citing works

Tissue distribution of the human MDR3 P-glycoprotein.

Smit, J., Schinkel, A. H., Mol, C. A. A. M., Majoor, D. M., Mooi, W. J., Jongsma, A. P. M., Lincke, C. R., & Borst, P. (1994) · PubMed · Cited by 150 · see citing works

Peroxisome Proliferator‐activated Receptors: Stuctures and Function

Tugwood, J. D., Aldridge, T. C., Lambe, K. G., MACDONALD, N., & Woodyatt, N. J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18620.x · Cited by 149 · see citing works

Altered localization and activity of canalicular Mrp2 in estradiol-17β-D-glucuronide-induced cholestasis

Mottino, A. D., Cao, J., Veggi, L. M., Crocenzi, F. A., Roma, M. G., & Vore, M. E. (2002) · Hepatology · doi:10.1053/jhep.2002.33327 · Cited by 149 · see citing works

Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse

José Chianale, B., Vollrath, V., Wielandt, A. M., Amigo, L., Rigotti, A., Nervi, F. O., González, S., ANDRADE, L., Pizarro, M., & Luigi Accatino, L. (1996) · Biochemical Journal · doi:10.1042/bj3140781 · Cited by 143 · see citing works

Newly Synthesized Canalicular ABC Transporters Are Directly Targeted from the Golgi to the Hepatocyte Apical Domain in Rat Liver

Kipp, H., & Arias, I. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909875199 · Cited by 131 · see citing works

Cellular regulation of hepatic bile acid transport in health and cholestasis

Anwer, S. M. (2004) · Hepatology · doi:10.1002/hep.20090 · Cited by 129 · see citing works

Hepatocyte-specific expression of the human MDR3 P -glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (−/−) mice

Smith, A. J., Vree, M., Ottenhoff, R., Elferink, R. P. J. O., Schinkel, A. H., & Borst, P. (1998) · Hepatology · doi:10.1002/hep.510280234 · Cited by 123 · see citing works

Bezafibrate in The Treatment of Primary Biliary Cirrhosis: Comparison With Ursodeoxycholic Acid

Kurihara, T., Niimi, A., Maeda, A., Shigemoto, M., & Yamashita, K. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03220.x · Cited by 117 · see citing works

Fibrate and Statin Synergistically Increase the Transcriptional Activities of PPARα/RXRα and Decrease the Transactivation of NFκB

Inoue, I., Itoh, F., Aoyagi, S., Tazawa, S., Kusama, H., Akahane, M., Mastunaga, T., Hayashi, K., Awata, T., Komoda, T., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6141 · Cited by 115 · see citing works

Protein Kinase C-Dependent Distribution of the Multidrug Resistance Protein 2 From the Canalicular to the Basolateral Membrane in Human Hepg2 Cells

Kubitz, R., Huth, C., Schmitt, M., Horbach, A., Kullak-Ublick, G. A., & Häussinger, D. (2001) · Hepatology · doi:10.1053/jhep.2001.25959 · Cited by 110 · see citing works

Ethinylestradiol administration selectively alters liver sinusoidal membrane lipid fluidity and protein composition

Rosario, J., Sutherland, E. W., Zaccaro, L. M., & Simon, F. R. (1988) · Biochemistry · doi:10.1021/bi00411a008 · Cited by 104 · see citing works

Intracellular Trafficking and Regulation of Canalicular ATP-Binding Cassette Transporters

Kipp, H., & Arias, I. M. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9388 · Cited by 91 · see citing works

Induction of hepatic ABC transporter expression is part of the PPARα–mediated fasting response in the mouse

Kok, T., Wolters, H., Bloks, V. W., Havinga, R., Jansen, P. L. M., Staels, B., & Kuipers, F. (2003) · Gastroenterology · doi:10.1053/gast.2003.50007 · Cited by 86 · see citing works

Enhancement of Mdr2-mediated Phosphatidylcholine Translocation by the Bile Salt Taurocholate

Ruetz, S., & Gros, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25388 · Cited by 85 · see citing works

Sphingolipid Transport to the Apical Plasma Membrane Domain in Human Hepatoma Cells Is Controlled by PKC and PKA Activity: A Correlation with Cell Polarity in HepG2 Cells

Zegers, M. M., & Hoekstra, D. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.2.307 · Cited by 83 · see citing works

Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts

Sagawa, H., Tazuma, S., & Kajiyama, G. (1993) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1993.264.5.g835 · Cited by 76 · see citing works

In vitro Evidence that Phospholipid Secretion into Bile May Be Coordinated Intracellularly by the Combined Actions of Bile Salts and the Specific Phosphatidylcholine Transfer Protein of Liver

Cohen, D. E., Leonard, M. R., & Carey, M. C. (1994) · Biochemistry · doi:10.1021/bi00199a021 · Cited by 76 · see citing works

Etiologic Significance of Defects in Cholesterol, Phospholipid, and Bile Acid Metabolism in the Liver of Patients With Intrahepatic Calculi

Shoda, J., Oda, K., Suzuki, H., Sugiyama, Y., Ito, K., Cohen, D. E., Feng, L., Kamiya, J., Nimura, Y., Miyazaki, H., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.23936 · Cited by 69 · see citing works

Specific Inhibition of AQP1 Water Channels in Isolated Rat Intrahepatic Bile Duct Units by Small Interfering RNAs

Splinter, P. L., Masyuk, A. I., & LaRusso, N. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212079200 · Cited by 62 · see citing works

Evidence for a Causal Role of CD38 Expression in Granulocytic Differentiation of Human HL-60 Cells

Munshi, C. B., Graeff, R. M., & Lee, H. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209313200 · Cited by 61 · see citing works

Vesicular and Nonvesicular Transport of Phosphatidylcholine in Polarized HepG2 Cells

Wüstner, D., Mukherjee, S., Maxfield, F. R., Müller, P. K., & Herrmann, A. (2001) · Traffic · doi:10.1034/j.1600-0854.2001.9o135.x · Cited by 39 · see citing works

Cloning, tissue-specific expression, gene structure and chromosomal localization of human phosphatidylcholine transfer protein

Cohen, D. E., Green, R. M., Wu, M. K., & Beier, D. R. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00163-3 · Cited by 29 · see citing works

Clofibrate-Induced Relocation of Phosphatidylcholine Transfer Protein to Mitochondria in Endothelial Cells

de Brouwer, A. P. M., Westerman, J., Kleinnijenhuis, A. J., Bevers, L. M., Roelofsen, B., & WIRTZ, K. W. A. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5460 · Cited by 27 · see citing works

Lipid Transport from the Hepatocyte into the Bile

Rigotti, A., Marzolo, M., & Nervi, F. O. (1994) · Current topics in membranes · doi:10.1016/s0070-2161(08)60997-1 · Cited by 27 · see citing works

Cloning and gene structure of rat phosphatidylcholine transfer protein, Pctp

Wu, M. K., Boylan, M. O., & Cohen, D. E. (1999) · Gene · doi:10.1016/s0378-1119(99)00204-8 · Cited by 16 · see citing works

A lipid lowering drug(Bezafibrate) has a favorable effect on liver enzymes(Al-P and .GAMMA.-GTP).

Fukuo, Y., Kitami, T., Nomoto, T., & Terashi, A. (1996) · Journal of Nippon Medical School · doi:10.1272/jnms1923.63.424 · Cited by 13 · see citing works

New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond

Beuers, U., Trauner, M., Jansen, P., & Poupon, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.023 · Cited by 537 · see citing works

Bile acid transporters and regulatory nuclear receptors in the liver and beyond

Halilbasic, E., Claudel, T., & Trauner, M. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.002 · Cited by 397 · see citing works

Fibrates and cholestasis

Ghonem, N. S., Assis, D. N., & Boyer, J. L. (2015) · Hepatology · doi:10.1002/hep.27744 · Cited by 317 · see citing works

Primary biliary cholangitis: pathogenesis and therapeutic opportunities

Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308 · see citing works

Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)

Elferink, R. P. J. O., & Paulusma, C. C. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0062-9 · Cited by 279 · see citing works

Novel therapeutic targets for cholestatic and fatty liver disease

Trauner, M., & Fuchs, C. D. (2022) · Gut · doi:10.1136/gutjnl-2021-324305 · Cited by 204 · see citing works

Nuclear receptors as therapeutic targets in cholestatic liver diseases

Zollner, G., & Trauner, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00030.x · Cited by 146 · see citing works

Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases

Halilbasic, E., Baghdasaryan, A., & Trauner, M. A. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.12.001 · Cited by 98 · see citing works

Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity

Zollner, G., Wagner, M., & Trauner, M. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.03.005 · Cited by 89 · see citing works

Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion

Ghonem, N. S., Ananthanarayanan, M., Soroka, C. J., & Boyer, J. L. (2013) · Hepatology · doi:10.1002/hep.26894 · Cited by 86 · see citing works

Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers

Okada, K., Shoda, J., Kano, M., Suzuki, S., Ohtake, N., Yamamoto, M., Takahashi, H., Utsunomiya, H., Oda, K., Sato, K., et al. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00302.2006 · Cited by 85 · see citing works

Molecular Mechanisms for Biliary Phospholipid and Drug Efflux Mediated by ABCB4 and Bile Salts

Morita, S., & Terada, T. (2014) · BioMed Research International · doi:10.1155/2014/954781 · Cited by 77 · see citing works

PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales

Colapietro, F., Gershwin, M. E., & Lleò, A. (2023) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2023.100188 · Cited by 76 · see citing works

Structure and Function of Hepatobiliary ATP Binding Cassette Transporters

Kroll, T., Prescher, M., Smits, S. H. J., & Schmitt, L. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00659 · Cited by 73 · see citing works

Drug Therapies for Chronic Cholestatic Liver Diseases

Wagner, M., & Fickert, P. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021059 · Cited by 72 · see citing works

Clinical application of transcriptional activators of bile salt transporters

Baghdasaryan, A., Chiba, P., & Trauner, M. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.12.001 · Cited by 56 · see citing works

Peroxisome Proliferator-activated Receptor α Positively Regulates Complement C3 Expression but Inhibits Tumor Necrosis Factor α-mediated Activation of C3 Gene in Mammalian Hepatic-derived Cells

Mogilenko, D. A., Кудрявцев, И. В., Shavva, V. S., Dizhe, E. B., Виленская, Е. Г., Efremov, A. M., Ap, P., & Orlov, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437525 · Cited by 53 · see citing works

Recent advances in understanding and managing cholestasis

Wagner, M., & Trauner, M. A. (2016) · F1000Research · doi:10.12688/f1000research.8012.1 · Cited by 53 · see citing works

Junctional Adhesion Molecule-A Is Critical for the Formation of Pseudocanaliculi and Modulates E-cadherin Expression in Hepatic Cells

Konopka, G., Tekiela, J., Iverson, M., Wells, C. W., & Duncan, S. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703592200 · Cited by 51 · see citing works

The cholangiographic features of severe forms of ABCB4/MDR3 deficiency-associated cholangiopathy in adults

Poupon, R. Y., Arrivé, L., & Rosmorduc, O. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2010.04.011 · Cited by 47 · see citing works

The multiple facets of ABCB4 (MDR3) deficiency

Sundaram, S. S., & Sokol, R. J. (2007) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-007-0049-4 · Cited by 41 · see citing works

Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor‐β1 in a cultured stellate cell line

Nakano, S., Nagasawa, T., Ijiro, T., Inada, Y., Tamura, T., Maruyama, K., Kuroda, J., Yamazaki, Y., Kusama, H., & Shibata, N. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00363.x · Cited by 39 · see citing works

Pioglitazone Stimulates Apolipoprotein A-I Production Without Affecting HDL Removal in HepG2 Cells

Qin, S., Liu, T., Kamanna, V. S., & Kashyap, M. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.150193 · Cited by 37 · see citing works

Fibrate treatment for primary biliary cirrhosis

Cuperus, F. J. C., Halilbasic, E., & Trauner, M. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000056 · Cited by 36 · see citing works

Cholestatic Liver Diseases from Child to Adult: The Diversity of MDR3 Disease

Kubitz, R., Bode, J. G., Erhardt, A., Graf, D., KIRCHEIS, G., Müller‐Stöver, I., Reinehr, R., Reuter, S., Richter, J., Sagir, A., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0031-1273427 · Cited by 36 · see citing works

Receptor for activated C‐kinase 1 regulates the cellular localization and function of ABCB4

Ikebuchi, Y., Takada, T., Ito, K., Yoshikado, T., Anzai, N., Kanai, Y., & Suzuki, H. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00544.x · Cited by 35 · see citing works

Therapy of Primary Sclerosing Cholangitis - Today and Tomorrow

Halilbasic, E., Fuchs, C. D., Hofer, H., Paumgartner, G., & Trauner, M. (2015) · Digestive Diseases · doi:10.1159/000440827 · Cited by 33 · see citing works

Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial

Bolier, R., de Vries, E. S., Parés, A. R., Helder, J., Kemper, E. M., Zwinderman, K. H., Elferink, R. P. J. O., & Beuers, U. H. (2017) · Trials · doi:10.1186/s13063-017-1966-8 · Cited by 32 · see citing works

The association of ABC proteins with multidrug resistance in cancer

Marques, A. V. L., Ruginsk, B. E., Prado, L. D. O., de Lima, D. E., Daniel, I. W., Moure, V. R., & Valdameri, G. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119878 · Cited by 28 · see citing works

Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems

Fernández-Murga, M. L., Petrov, P., Conde, I., Castell, J. V., Gómez‐Lechón, M. J., & Jover, R. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.07.017 · Cited by 28 · see citing works

ACBP Knockdown Leads to Down-regulation of Genes Encoding Rate-limiting Enzymes in Cholesterol and Fatty Acid Metabolism

Vock, C., Biedasek, K., Boomgaarden, I., Steffen‐Heins, A., Nitz, I., & Döring, F. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315087 · Cited by 28 · see citing works

Bile acid signaling in MASLD: From pathogenesis to therapeutic applications

Simbrunner, B., Paternostro, R., Reiberger, T., & Trauner, M. (2025) · Hepatology · doi:10.1097/hep.0000000000001539 · Cited by 26 · see citing works

Bezafibrate induces multidrug‐resistance P‐Glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice

Shoda, J., Okada, K., Inada, Y., Kusama, H., Utsunomiya, H., Oda, K., Yokoi, T., Yoshizato, K., & Suzuki, H. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00069.x · Cited by 26 · see citing works

8-Methoxypsoralen disrupts MDR3-mediated phospholipids efflux and bile acid homeostasis and its relevance to hepatotoxicity

Zhao, G., Xu, D., Yuan, Z., Jiang, Z., Zhou, W., Li, Z., Yin, M., Zhou, Z., Zhang, L., & Wang, T. (2017) · Toxicology · doi:10.1016/j.tox.2017.05.011 · Cited by 26 · see citing works

Activation and Expression of Peroxisome Proliferator-Activated Receptor Alpha Are Associated with Tumorigenesis in Colorectal Carcinoma

Morinishi, T., Tokuhara, Y., Ohsaki, H., Ibuki, E., Kadota, K., & Hirakawa, E. (2019) · PPAR Research · doi:10.1155/2019/7486727 · Cited by 26 · see citing works

ABCB4/MDR3 in health and disease – at the crossroads of biochemistry and medicine

Prescher, M., Kroll, T., & Schmitt, L. (2019) · Biological Chemistry · doi:10.1515/hsz-2018-0441 · Cited by 25 · see citing works

PPAR Medicines and Human Disease: The ABCs of It All

Apostoli, A. J., & Nicol, C. J. B. (2012) · PPAR Research · doi:10.1155/2012/504918 · Cited by 22 · see citing works

Tumor necrosis factor α stimulates endogenous apolipoprotein A-I expression and secretion by human monocytes and macrophages: role of MAP-kinases, NF-κB, and nuclear receptors PPARα and LXRs

Shavva, V. S., Mogilenko, D. A., Nekrasova, E. V., Trulioff, A. S., Кудрявцев, И. В., Larionova, E. E., Babina, A. V., Dizhe, E. B., Missyul, B. V., & Orlov, S. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3327-7 · Cited by 22 · see citing works

Targeting the ABCB4 gene to control cholesterol homeostasis

Elferink, R. P. J. O., & Beuers, U. H. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.607163 · Cited by 22 · see citing works

Thyroid hormone receptor β1 stimulates ABCB4 to increase biliary phosphatidylcholine excretion in mice

Gautherot, J., Claudel, T., Cuperus, F. J. C., Fuchs, C. D., Falguières, T., & Trauner, M. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m084145 · Cited by 20 · see citing works

The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression

Enjoji, M., Yada, R., Fujino, T., Yoshimoto, T., Yada, M., Harada, N., Higuchi, N., Kato, M., Kohjima, M., Taketomi, A., et al. (2009) · Hepatology International · doi:10.1007/s12072-009-9137-y · Cited by 19 · see citing works

Alterations in cellular and organellar phospholipid compositions of HepG2 cells during cell growth

Tsuji, T., Morita, S., Nakamura, Y., Ikeda, Y., Kambe, T., & Terada, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-81733-3 · Cited by 18 · see citing works

Choleretic effect of inchinkoto, a herbal medicine, on livers of patients with biliary obstruction due to bile duct carcinoma

Watanabe, S., Yokoyama, Y., Oda, K., Kokuryo, T., Shoda, J., Okada, K., Utsunomiya, H., & Nagino, M. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00453.x · Cited by 18 · see citing works

Lipid Metabolism and the Liver

Enjoji, M., Kohjima, M., & Nakamuta, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55790-6_6 · Cited by 17 · see citing works

A Human Hepatocyte‐Bearing Mouse: An Animal Model to Predict Drug Metabolism and Effectiveness in Humans

Yoshizato, K., & Tateno, C. (2009) · PPAR Research · doi:10.1155/2009/476217 · Cited by 17 · see citing works

Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism

Kohjima, M., Enjoji, M., Yada, R., Yoshimoto, T., Nakamura, T., Fukuizumi, K., Fukushima, N., Murata, Y., Nakashima, M., Kato, M., et al. (2014) · Liver International · doi:10.1111/liv.12526 · Cited by 16 · see citing works

Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis–1 deficiency manifesting progressive familial intrahepatic cholestasis

Nagasaka, H., Yorifuji, T., Hirano, K., Ota, A., Nakagawa-Toyama, Y., Takatani, T., Tsukahara, H., Kobayashi, K., Takayanagi, M., Inomata, Y., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.005 · Cited by 12 · see citing works

Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments

Gabrielli, F., Crepaldi, E., Cavicchioli, A., Rivi, M., Costanzo, A. A. C., Cursaro, C., & Andreoné, P. (2024) · Biomolecules · doi:10.3390/biom14101227 · Cited by 10 · see citing works

Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumption

Iwasa, M., Sugimoto, R., Eguchi, A., Tamai, Y., Shigefuku, R., Fujiwara, N., Tanaka, H., Kobayashi, Y., Ikoma, J., Kaito, M., et al. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002766 · Cited by 9 · see citing works

ABC transporters involved in respiratory and cholestatic diseases: From rare to very rare monogenic diseases

Lakli, M., Onnée, M., Carrez, T., Becq, F., Falguières, T., & Fanen, P. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116468 · Cited by 8 · see citing works

Evaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitis

Caines, A., Trudeau, S., & Gordon, S. C. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2390120 · Cited by 7 · see citing works

Evaluating the effect of a mixture of two main conjugated linoleic acid isomers on hepatic steatosis in HepG2 cellular model

Jalilian, A., Golmohammadi, T., Meshkani, R., Koushki, M., Eivazi, N., Khorzoughi, R. B., Hosseini‐Fard, S. R., & Paknejad, M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06203-5 · Cited by 6 · see citing works

Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis

Schattenberg, J. M., Bañales, J. M., Hirschfield, G. M., Trivedi, P., Cable, E. E., McWherter, C. A., Billin, A. N., Crittenden, D. B., & Budas, G. R. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70598 · Cited by 5 · see citing works

Cholangite sclérosante de réanimation : évolution favorable sous acide ursodésoxycholique et fénofibrate

Bélénotti, P., Guervilly, C., Grandval, P., Benyamine, A., Ené, N., Serratrice, J., Petit, P., Laugier, R., Papazian, L., & Weiller, P. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.10.376 · Cited by 3 · see citing works

Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression

Catanzaro, E., Peviani, M., Bonaiuto, E., Pezzato, F., Benatti, M., Cavaliere, C., Perin, N., Russo, F. P., Gambato, M., Burra, P., et al. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.04.017 · Cited by 2 · see citing works

Inheritable Cholestatic Disorders

Gissen, P., & Knisely, A. S. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch42 · Cited by 2 · see citing works

Fibrate therapy in primary sclerosing cholangitis: missing data on lipids, interactions, and cancer risk

Wu, Y., & Yang, Z. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.06.006 · Cited by 1 · see citing works

Terapias usuales y emergentes en colangitis biliar primaria

Díaz-Duque, J. C., Palacio-Valencia, V., Suárez-Meneses, J., Montaña-López, J. A., & Palacio-Sánchez, E. (2022) · Hepatología · doi:10.52784/27112330.156

Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway

Nakamuta, M., Fujino, T., Yada, R., Yasutake, K., Yoshimoto, T., Harada, N., Yada, M., Higuchi, N., Kato, M., Kohjima, M., et al. (2010) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp48022 · Cited by 22 · see citing works

Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion

Ghonem, N. S., Ananthanarayanan, M., Soroka, C. J., & Boyer, J. L. (2013) · Hepatology · doi:10.1002/hep.26894 · Cited by 86 · see citing works

A Nuclear Receptor-mediated Choleretic Action of Fibrates is Associated with Enhanced Canalicular Membrane Fluidity and Transporter Activity Mediating Bile Acid-independent Bile Secretion

Nishioka, T., Hyogo, H., Numata, Y., Yamaguchi, A., Kobuke, T., Komichi, D., Nonaka, M., Inoue, M., Nabeshima, Y., Ogi, M., et al. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.211 · Cited by 17 · see citing works

Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid

Honda, A., Ikegami, T., Nakamuta, M., Miyazaki, T., Iwamoto, J., Hirayama, T., Saito, Y., Takikawa, H., Imawari, M., & Matsuzaki, Y. (2013) · Hepatology · doi:10.1002/hep.26018 · Cited by 210 · see citing works

Effects of Fibrate Drugs on Expression of ABCA1 and HDL Biogenesis in Hepatocytes

Hossain, M. A., Tsujita, M., Gonzalez, F. J., & Yokoyama, S. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181624b22 · Cited by 58 · see citing works